Analysis of humoral immunity of hepatitis D virus DNA vaccine generated in mice by using different dosage, gene gun immunization, and in vivo electroporation

Journal of the Chinese Medical Association

Volumn 69, Issue 1, 2006, Pages 7-13

  Shiau, Yih Tsong ^a   Huang, Yi Hsiang ^a,b   Wu, Jaw Ching ^a,b   Tao, Mi Hua ^c   Syu, Wan Jr ^b   Chang, Full Young ^a,b   Lee, Shou Dong ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

DNA vaccine; Gene gun; Hepatitis D virus; In vivo electroporation

Indexed keywords

DNA VACCINE; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS DELTA ANTIGEN; VIRUS DNA;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; ELECTROPORATION; FEMALE; GENE DELIVERY SYSTEM; GENE DOSAGE; GENE GUN; GENETIC CODE; HEPATITIS DELTA VIRUS; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; IMMUNOSTIMULATION; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; SEROCONVERSION;

EID: 31344431532     PISSN: 17264901     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1726-4901(09)70104-2     Document Type: Article

References (32)

1. Rizzetto M, Canese MG, Gerin JL, London WT, Sly DL, Purcell RH. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis 1980;141:590-602.
2. Wu JC, Chen PJ, Kuo MY, Lee SD, Chen DS, Ting LP. Production of hepatitis delta virus and suppression of helper hepatitis B virus in a human hepatoma cell line. J Virol 1991; 65:1099-104.
3. Davey S. State of the World's Vaccines and Immunization. Geneva: World Health Organization, 1996:76-82.
4. Gaeta GB, Stroffolini T, Chiaramonte M, Ascione T, Stornaiuolo G, Lobello S, Sagnelli E, et al. Chronic hepatitis D: a vanishing disease? An Italian multicenter study. Hepatology 2000;32: 824-7.
5. Radjef N, Gordien E, Ivaniushina V, Gault E, Anais P, Drugan T, Trinchet JC, et al. Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a delta virus genus of at least seven major clades. J Virol 2004;78:2537-44.
6. Wu JC, Chen CL, Hou MC, Chen TZ, Lee SD, Lo KJ. Multiple viral infections as the most common cause of fulminant and subfulminant viral hepatitis in an endemic area for hepatitis B: application and limitations of polymerase chain reaction. Hepatology 1994;19:836-40.
7. Govindarajan S, De Cock KM, Redeker AG. Natural course of delta superinfection in chronic hepatitis B virus-infected patients: histologic study with multiple liver biopsies. Hepatology 1986; 6:640-4.
8. Rizzetto M, Verme G, Recchia S, Bonino F, Farci P, Arico S, Calzia R, et al. Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med 1983;98: 437-41.
9. Wu JC, Lee SD, Govindarajan S, Kung TW, Tsai YT, Lo KJ, Ting LP. Correlation of serum delta RNA with clinical course of acute delta virus superinfection in Taiwan: a longitudinal study. J Infect Dis 1990;161:1116-20.
10. Wu JC, Chen TZ, Huang YS, Yen FS, Ting LT, Sheng WY, Tsay SH, et al. Natural history of hepatitis D viral superinfection - significance of viremia detected by polymerase chain reaction. Gastroenterology 1995;108:796-802.
11. Fattovich G, Giustina G, Christensen E, Pantalena M, Zagni I, Realdi G, Schalm SW. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. Gut 2000;46:420-6.
12. Farci P, Mandas A, Coiana A, Lai ME, Desmet V, Van Eyken P, Gibo Y, et al. Treatment of chronic hepatitis D with interferon alfa-2a. N Engl J Med 1994;330:88-94.
13. Lau DT, Doo E, Park Y, Kleiner DE, Schmid P, Kuhns MC, Hoofnagle JH. Lamivudine for chronic delta hepatitis. Hepatology 1999;30:546-9.
14. Casey JL, Bergmann KF, Brown TL, Gerin JL. Structural requirement for RNA editing in hepatitis D virus: evidence for a uridine-to-cytidine editing mechanism. Proc Natl Acad Sci USA 1992;89:7149-53.
15. Casey JL, Gerin JL. Hepatitis D virus RNA editing: specific modification of adenosine in the antigenomic RNA. J Virol 1995;69:7593-600.
16. Glenn JS, Watson JA, Havel CM, White JM. Identification of a prenylation site in delta virus large antigen. Science 1992;256: 1331-3.
17. Huang YH, Wu JC, Tao MH, Syu WJ, Hsu SC, Chi WK, Chang FY, et al. DNA-based immunization produces Th1 immune response to hepatitis delta virus in a mouse model. Hepatology 2000;32:104-10.
18. Huang YH, Wu JC, Hsu SC, Syu WJ. Varied immunity generated in mice by DNA vaccines with large and small hepatitis delta antigens. J Virol 2003;77:12980-5.
19. Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci USA 1993;90:11478-82.
20. Widera G, Austin M, Rabussay D, Goldbeck C, Barnett SW, Chen M, Leung L, et al. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol 2000; 164:4635-40.
21. Zucchelli S, Capone S, Fattori E, Folgori A, Di Marco A, Casimiro D, Simon AJ, et al. Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer. J Virol 2000;74:11598-607.
22. Chow YH, Huang WL, Chi WK, Chu YD, Tao MH. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J Virol 1997;71:169-78.
23. Chen HW, Pan CH, Liau MY, Jou R, Tsai CJ, Wu HJ, Lin YL, et al. Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines. J Virol 1999;73:10137-45.
24. Aihara H, Miyazaki J. Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 1998;16:867-70.
25. Lee SC, Wu CJ, Wu PY, Huang YL, Wu CW, Tao MH. Inhibition of established subcutaneous and metastatic murine tumors by intramuscular electroporation of the interleukin-12 gene. J Biomed Sci 2003;10:73-86.
26. Hsu SC, Yan BS, Pan JM, Syu WJ. A monoclonal antibody reacts with maltose-binding protein of Escherichia coli and related enteric bacteria. J Immunol Methods 1997;204:169-74.
27. Kruskal WH, Wallis WA. Use of ranks in one criterion variance analysis. J Am Stat Assoc 1952;47:583-621.
28. Roy MJ, Wu MS, Barr LJ, Fuller JT, Tussey LG, Speller S, Culp J, et al. Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine. Vaccine 2000;19:764-78.
29. Swain WE, Heydenburg Fuller D, Wu MS, Barr LJ, Fuller JT, Culp J, Burkholder J, et al. Tolerability and immune responses in humans to a PowderJect DNA vaccine for hepatitis B. Dev Biol 2000;104:115-9.
30. Mauch C, Grimm C, Meckel S, Wands JR, Blum HE, Roggendorf M, Geissler M. Induction of cytotoxic T lymphocyte responses against hepatitis delta virus antigens which protect against tumor formation in mice. Vaccine 2001;20:170-80.
31. Fiedler M, Lu M, Siegel F, Whipple J, Roggendorf M. Immunization of woodchucks (Marmota monax) with hepatitis delta virus DNA vaccine. Vaccine 2001;19:4618-26.
32. Wu JC, Chiang TY, Shiue WK, Wang SY, Sheen IJ, Huang YH, Syu WJ. Recombination of hepatitis D virus RNA sequences and its implications. Mol Biol Evol 1999;16:1622-32.